Search by Drug Name or NDC
NDC 68788-9539-02 Cephalexin 250 mg/5mL Details
Cephalexin 250 mg/5mL
Cephalexin is a ORAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Preferred Pharmaceuticals, Inc.. The primary component is CEPHALEXIN.
MedlinePlus Drug Summary
Cephalexin is used to treat certain infections caused by bacteria such as pneumonia and other respiratory tract infections; and infections of the bone, skin, ears, , genital, and urinary tract. Cephalexin is in a class of medications called cephalosporin antibiotics. It works by killing bacteria. Antibiotics such as cephalexin will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 68788-9539-02Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Cephalexin
Product Information
NDC | 68788-9539 |
---|---|
Product ID | 68788-9539_e12b622a-fc89-4f4e-871e-c651fa5e612a |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Cephalexin |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Cephalexin |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | POWDER, FOR SUSPENSION |
Route | ORAL |
Active Ingredient Strength | 250 |
Active Ingredient Units | mg/5mL |
Substance Name | CEPHALEXIN |
Labeler Name | Preferred Pharmaceuticals, Inc. |
Pharmaceutical Class | Cephalosporin Antibacterial [EPC], Cephalosporins [CS] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA062703 |
Listing Certified Through | 2024-12-31 |
Package
NDC 68788-9539-02 (68788953902)
NDC Package Code | 68788-9539-2 |
---|---|
Billing NDC | 68788953902 |
Package | 200 mL in 1 BOTTLE (68788-9539-2) |
Marketing Start Date | 2013-12-03 |
NDC Exclude Flag | N |
Pricing Information | N/A |